News and Updates

Each year, BWXT Medical submits a comprehensive Annual Compliance Report (ACR) to the Canadian Nuclear Safety Commission (CNSC) for its Kanata facility. …

(OTTAWA, Ontario – June 7, 2024) – BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Drug and …

BWXT Medical conducts community surveys to obtain feedback on its public information program, including its strengths and key areas for improvement in …

Agreement Furthers BWXT Medical’s Position as a Global Leader in Actinium Supply Collaboration Enables Fusion to Produce High Purity Actinium-225 at its …

(Ottawa, Ontario – February 1, 2023) – Life-saving Molybdenum-99 (Mo-99) isotopes can now be produced at Ontario Power Generation’s (OPG) Darlington Nuclear …

Agreement augments Fusion’s existing isotope supply as pipeline of clinical stage actinium-based radiopharmaceuticals grows  Furthers BWXT Medical’s position as a global leader …

Stay Connected:

Key Contacts:

Community Inquiries:
Phone: 1.833.657.4565
email: [email protected]

Job Seekers:
Please visit www.bwxt.com/careers
for current opportunities.

For urgent media inquiries, please contact:
Monifa Miller
Senior Director, Corporate Affairs
+1 519.242.8071
[email protected]

This Website Uses Cookies.

We use cookies to give you the best user experience. No personal information is collected in this process.